Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record presents details for the completed Phase II APL-2 trial, including participant criteria, treatment plan, measured outcomes, and study locations. It also includes posted results and supporting study documents.
    Difference
    56%
    Check dated 2026-11-09T13:36:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T13:50:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:56:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:08:09.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:44.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed the 403 error page elements (doctype, meta tags and Home link), resulting in the study details page becoming accessible again.
    Difference
    0.5%
    Check dated 2026-09-28T16:30:40.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.